Medical Care

Global Modified Peptide Synthesis Services Market Research Report 2025

The global market for Modified Peptide Synthesis Services was valued at US$ 634 million in the year 2024 and is projected to reach a revised size of US$ 904 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Modified peptide synthesis service refers to the introduction of specific modification groups into the peptide chain by chemical methods to enhance the function, stability and biological activity of the peptide. These modifications can include phosphorylation, methylation, acetylation, fluorescent labeling, etc. Modified peptides are widely used in drug development, protein interaction research, diagnostic reagent development and other fields.
North American market for Modified Peptide Synthesis Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Modified Peptide Synthesis Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Modified Peptide Synthesis Services in Basic Biological Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Modified Peptide Synthesis Services include Thermo Scientific, Biomatik, GenScript, Bachem, Covalab, LifeTein, Macrogen, Immunostep, Bio-Synthesis, Elabsciense, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Modified Peptide Synthesis Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Modified Peptide Synthesis Services.
The Modified Peptide Synthesis Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Modified Peptide Synthesis Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Modified Peptide Synthesis Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Scientific
Biomatik
GenScript
Bachem
Covalab
LifeTein
Macrogen
Immunostep
Bio-Synthesis
Elabsciense
Abclonal
BioCat
Anaspec
Eurogentec
BioGenes
Segment by Type
Phosphorylated Peptide Synthesis
Methylated Peptide Synthesis
Other
Segment by Application
Basic Biological Research
Drug Development
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Modified Peptide Synthesis Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Modified Peptide Synthesis Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Phosphorylated Peptide Synthesis
1.2.3 Methylated Peptide Synthesis
1.2.4 Other
1.3 Market by Application
1.3.1 Global Modified Peptide Synthesis Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Basic Biological Research
1.3.3 Drug Development
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Modified Peptide Synthesis Services Market Perspective (2020-2031)
2.2 Global Modified Peptide Synthesis Services Growth Trends by Region
2.2.1 Global Modified Peptide Synthesis Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Modified Peptide Synthesis Services Historic Market Size by Region (2020-2025)
2.2.3 Modified Peptide Synthesis Services Forecasted Market Size by Region (2026-2031)
2.3 Modified Peptide Synthesis Services Market Dynamics
2.3.1 Modified Peptide Synthesis Services Industry Trends
2.3.2 Modified Peptide Synthesis Services Market Drivers
2.3.3 Modified Peptide Synthesis Services Market Challenges
2.3.4 Modified Peptide Synthesis Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Modified Peptide Synthesis Services Players by Revenue
3.1.1 Global Top Modified Peptide Synthesis Services Players by Revenue (2020-2025)
3.1.2 Global Modified Peptide Synthesis Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Modified Peptide Synthesis Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Modified Peptide Synthesis Services Revenue
3.4 Global Modified Peptide Synthesis Services Market Concentration Ratio
3.4.1 Global Modified Peptide Synthesis Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Modified Peptide Synthesis Services Revenue in 2024
3.5 Global Key Players of Modified Peptide Synthesis Services Head office and Area Served
3.6 Global Key Players of Modified Peptide Synthesis Services, Product and Application
3.7 Global Key Players of Modified Peptide Synthesis Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Modified Peptide Synthesis Services Breakdown Data by Type
4.1 Global Modified Peptide Synthesis Services Historic Market Size by Type (2020-2025)
4.2 Global Modified Peptide Synthesis Services Forecasted Market Size by Type (2026-2031)
5 Modified Peptide Synthesis Services Breakdown Data by Application
5.1 Global Modified Peptide Synthesis Services Historic Market Size by Application (2020-2025)
5.2 Global Modified Peptide Synthesis Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Modified Peptide Synthesis Services Market Size (2020-2031)
6.2 North America Modified Peptide Synthesis Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Modified Peptide Synthesis Services Market Size by Country (2020-2025)
6.4 North America Modified Peptide Synthesis Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Modified Peptide Synthesis Services Market Size (2020-2031)
7.2 Europe Modified Peptide Synthesis Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Modified Peptide Synthesis Services Market Size by Country (2020-2025)
7.4 Europe Modified Peptide Synthesis Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Modified Peptide Synthesis Services Market Size (2020-2031)
8.2 Asia-Pacific Modified Peptide Synthesis Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Modified Peptide Synthesis Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Modified Peptide Synthesis Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Modified Peptide Synthesis Services Market Size (2020-2031)
9.2 Latin America Modified Peptide Synthesis Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Modified Peptide Synthesis Services Market Size by Country (2020-2025)
9.4 Latin America Modified Peptide Synthesis Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Modified Peptide Synthesis Services Market Size (2020-2031)
10.2 Middle East & Africa Modified Peptide Synthesis Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Modified Peptide Synthesis Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Modified Peptide Synthesis Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Scientific
11.1.1 Thermo Scientific Company Details
11.1.2 Thermo Scientific Business Overview
11.1.3 Thermo Scientific Modified Peptide Synthesis Services Introduction
11.1.4 Thermo Scientific Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.1.5 Thermo Scientific Recent Development
11.2 Biomatik
11.2.1 Biomatik Company Details
11.2.2 Biomatik Business Overview
11.2.3 Biomatik Modified Peptide Synthesis Services Introduction
11.2.4 Biomatik Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.2.5 Biomatik Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Modified Peptide Synthesis Services Introduction
11.3.4 GenScript Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.3.5 GenScript Recent Development
11.4 Bachem
11.4.1 Bachem Company Details
11.4.2 Bachem Business Overview
11.4.3 Bachem Modified Peptide Synthesis Services Introduction
11.4.4 Bachem Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.4.5 Bachem Recent Development
11.5 Covalab
11.5.1 Covalab Company Details
11.5.2 Covalab Business Overview
11.5.3 Covalab Modified Peptide Synthesis Services Introduction
11.5.4 Covalab Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.5.5 Covalab Recent Development
11.6 LifeTein
11.6.1 LifeTein Company Details
11.6.2 LifeTein Business Overview
11.6.3 LifeTein Modified Peptide Synthesis Services Introduction
11.6.4 LifeTein Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.6.5 LifeTein Recent Development
11.7 Macrogen
11.7.1 Macrogen Company Details
11.7.2 Macrogen Business Overview
11.7.3 Macrogen Modified Peptide Synthesis Services Introduction
11.7.4 Macrogen Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.7.5 Macrogen Recent Development
11.8 Immunostep
11.8.1 Immunostep Company Details
11.8.2 Immunostep Business Overview
11.8.3 Immunostep Modified Peptide Synthesis Services Introduction
11.8.4 Immunostep Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.8.5 Immunostep Recent Development
11.9 Bio-Synthesis
11.9.1 Bio-Synthesis Company Details
11.9.2 Bio-Synthesis Business Overview
11.9.3 Bio-Synthesis Modified Peptide Synthesis Services Introduction
11.9.4 Bio-Synthesis Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.9.5 Bio-Synthesis Recent Development
11.10 Elabsciense
11.10.1 Elabsciense Company Details
11.10.2 Elabsciense Business Overview
11.10.3 Elabsciense Modified Peptide Synthesis Services Introduction
11.10.4 Elabsciense Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.10.5 Elabsciense Recent Development
11.11 Abclonal
11.11.1 Abclonal Company Details
11.11.2 Abclonal Business Overview
11.11.3 Abclonal Modified Peptide Synthesis Services Introduction
11.11.4 Abclonal Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.11.5 Abclonal Recent Development
11.12 BioCat
11.12.1 BioCat Company Details
11.12.2 BioCat Business Overview
11.12.3 BioCat Modified Peptide Synthesis Services Introduction
11.12.4 BioCat Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.12.5 BioCat Recent Development
11.13 Anaspec
11.13.1 Anaspec Company Details
11.13.2 Anaspec Business Overview
11.13.3 Anaspec Modified Peptide Synthesis Services Introduction
11.13.4 Anaspec Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.13.5 Anaspec Recent Development
11.14 Eurogentec
11.14.1 Eurogentec Company Details
11.14.2 Eurogentec Business Overview
11.14.3 Eurogentec Modified Peptide Synthesis Services Introduction
11.14.4 Eurogentec Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.14.5 Eurogentec Recent Development
11.15 BioGenes
11.15.1 BioGenes Company Details
11.15.2 BioGenes Business Overview
11.15.3 BioGenes Modified Peptide Synthesis Services Introduction
11.15.4 BioGenes Revenue in Modified Peptide Synthesis Services Business (2020-2025)
11.15.5 BioGenes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Modified Peptide Synthesis Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Phosphorylated Peptide Synthesis
Table 3. Key Players of Methylated Peptide Synthesis
Table 4. Key Players of Other
Table 5. Global Modified Peptide Synthesis Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Modified Peptide Synthesis Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Modified Peptide Synthesis Services Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Modified Peptide Synthesis Services Market Share by Region (2020-2025)
Table 9. Global Modified Peptide Synthesis Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Modified Peptide Synthesis Services Market Share by Region (2026-2031)
Table 11. Modified Peptide Synthesis Services Market Trends
Table 12. Modified Peptide Synthesis Services Market Drivers
Table 13. Modified Peptide Synthesis Services Market Challenges
Table 14. Modified Peptide Synthesis Services Market Restraints
Table 15. Global Modified Peptide Synthesis Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Modified Peptide Synthesis Services Market Share by Players (2020-2025)
Table 17. Global Top Modified Peptide Synthesis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Peptide Synthesis Services as of 2024)
Table 18. Ranking of Global Top Modified Peptide Synthesis Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Modified Peptide Synthesis Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Modified Peptide Synthesis Services, Headquarters and Area Served
Table 21. Global Key Players of Modified Peptide Synthesis Services, Product and Application
Table 22. Global Key Players of Modified Peptide Synthesis Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Modified Peptide Synthesis Services Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Modified Peptide Synthesis Services Revenue Market Share by Type (2020-2025)
Table 26. Global Modified Peptide Synthesis Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Modified Peptide Synthesis Services Revenue Market Share by Type (2026-2031)
Table 28. Global Modified Peptide Synthesis Services Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Modified Peptide Synthesis Services Revenue Market Share by Application (2020-2025)
Table 30. Global Modified Peptide Synthesis Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Modified Peptide Synthesis Services Revenue Market Share by Application (2026-2031)
Table 32. North America Modified Peptide Synthesis Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Modified Peptide Synthesis Services Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Modified Peptide Synthesis Services Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Modified Peptide Synthesis Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Modified Peptide Synthesis Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Modified Peptide Synthesis Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Modified Peptide Synthesis Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Modified Peptide Synthesis Services Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Modified Peptide Synthesis Services Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Modified Peptide Synthesis Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Modified Peptide Synthesis Services Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Modified Peptide Synthesis Services Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Modified Peptide Synthesis Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Modified Peptide Synthesis Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Modified Peptide Synthesis Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Scientific Company Details
Table 48. Thermo Scientific Business Overview
Table 49. Thermo Scientific Modified Peptide Synthesis Services Product
Table 50. Thermo Scientific Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 51. Thermo Scientific Recent Development
Table 52. Biomatik Company Details
Table 53. Biomatik Business Overview
Table 54. Biomatik Modified Peptide Synthesis Services Product
Table 55. Biomatik Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 56. Biomatik Recent Development
Table 57. GenScript Company Details
Table 58. GenScript Business Overview
Table 59. GenScript Modified Peptide Synthesis Services Product
Table 60. GenScript Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 61. GenScript Recent Development
Table 62. Bachem Company Details
Table 63. Bachem Business Overview
Table 64. Bachem Modified Peptide Synthesis Services Product
Table 65. Bachem Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 66. Bachem Recent Development
Table 67. Covalab Company Details
Table 68. Covalab Business Overview
Table 69. Covalab Modified Peptide Synthesis Services Product
Table 70. Covalab Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 71. Covalab Recent Development
Table 72. LifeTein Company Details
Table 73. LifeTein Business Overview
Table 74. LifeTein Modified Peptide Synthesis Services Product
Table 75. LifeTein Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 76. LifeTein Recent Development
Table 77. Macrogen Company Details
Table 78. Macrogen Business Overview
Table 79. Macrogen Modified Peptide Synthesis Services Product
Table 80. Macrogen Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 81. Macrogen Recent Development
Table 82. Immunostep Company Details
Table 83. Immunostep Business Overview
Table 84. Immunostep Modified Peptide Synthesis Services Product
Table 85. Immunostep Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 86. Immunostep Recent Development
Table 87. Bio-Synthesis Company Details
Table 88. Bio-Synthesis Business Overview
Table 89. Bio-Synthesis Modified Peptide Synthesis Services Product
Table 90. Bio-Synthesis Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 91. Bio-Synthesis Recent Development
Table 92. Elabsciense Company Details
Table 93. Elabsciense Business Overview
Table 94. Elabsciense Modified Peptide Synthesis Services Product
Table 95. Elabsciense Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 96. Elabsciense Recent Development
Table 97. Abclonal Company Details
Table 98. Abclonal Business Overview
Table 99. Abclonal Modified Peptide Synthesis Services Product
Table 100. Abclonal Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 101. Abclonal Recent Development
Table 102. BioCat Company Details
Table 103. BioCat Business Overview
Table 104. BioCat Modified Peptide Synthesis Services Product
Table 105. BioCat Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 106. BioCat Recent Development
Table 107. Anaspec Company Details
Table 108. Anaspec Business Overview
Table 109. Anaspec Modified Peptide Synthesis Services Product
Table 110. Anaspec Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 111. Anaspec Recent Development
Table 112. Eurogentec Company Details
Table 113. Eurogentec Business Overview
Table 114. Eurogentec Modified Peptide Synthesis Services Product
Table 115. Eurogentec Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 116. Eurogentec Recent Development
Table 117. BioGenes Company Details
Table 118. BioGenes Business Overview
Table 119. BioGenes Modified Peptide Synthesis Services Product
Table 120. BioGenes Revenue in Modified Peptide Synthesis Services Business (2020-2025) & (US$ Million)
Table 121. BioGenes Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report


List of Figures
Figure 1. Modified Peptide Synthesis Services Picture
Figure 2. Global Modified Peptide Synthesis Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Modified Peptide Synthesis Services Market Share by Type: 2024 VS 2031
Figure 4. Phosphorylated Peptide Synthesis Features
Figure 5. Methylated Peptide Synthesis Features
Figure 6. Other Features
Figure 7. Global Modified Peptide Synthesis Services Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Modified Peptide Synthesis Services Market Share by Application: 2024 VS 2031
Figure 9. Basic Biological Research Case Studies
Figure 10. Drug Development Case Studies
Figure 11. Other Case Studies
Figure 12. Modified Peptide Synthesis Services Report Years Considered
Figure 13. Global Modified Peptide Synthesis Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Modified Peptide Synthesis Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Modified Peptide Synthesis Services Market Share by Region: 2024 VS 2031
Figure 16. Global Modified Peptide Synthesis Services Market Share by Players in 2024
Figure 17. Global Modified Peptide Synthesis Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Modified Peptide Synthesis Services Revenue in 2024
Figure 19. North America Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Modified Peptide Synthesis Services Market Share by Country (2020-2031)
Figure 21. United States Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Modified Peptide Synthesis Services Market Share by Country (2020-2031)
Figure 25. Germany Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Modified Peptide Synthesis Services Market Share by Region (2020-2031)
Figure 33. China Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Modified Peptide Synthesis Services Market Share by Country (2020-2031)
Figure 41. Mexico Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Modified Peptide Synthesis Services Market Share by Country (2020-2031)
Figure 45. Turkey Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Modified Peptide Synthesis Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Thermo Scientific Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 49. Biomatik Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 50. GenScript Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 51. Bachem Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 52. Covalab Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 53. LifeTein Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 54. Macrogen Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 55. Immunostep Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 56. Bio-Synthesis Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 57. Elabsciense Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 58. Abclonal Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 59. BioCat Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 60. Anaspec Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 61. Eurogentec Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 62. BioGenes Revenue Growth Rate in Modified Peptide Synthesis Services Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies